Parnell Pharmaceuticals Holdings Ltd., an integrated pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. It operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. The company's marketed products include estroPLAN and GONAbreed reproductive hormones that are used to enhance breeding programs in dairy and beef cows; Zydax, a disease modifying osteoarthritis (OA) drug in dogs and horses; Glyde, a nutraceutical product for the treatment of OA in dogs , which contains a therapeutic dose of cartilage constituents, such as glucosamine and chondroitin, as well as natural anti-inflammatory; and Tergive, an injectable non-steroidal anti-inflammatory drug that contains carprofen. It is also developing PAR081 for anesthetics, PAR101 for metabolic diseases, PAR121 for orthopedics, PAR122 for dermatology, PAR061 for mastitis, and Gonadapro for reproduction in dairy cows. The company was incorporated in 2009 and is based in Alexandria, Australia.
Parnell Pharmaceuticals Holdings Ltd., an integrated pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions.
